title: Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations.
authors.affiliation: Departments of Medicine and Physiology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Arthur M
authors.initials: AM
authors.lastname: Feldman
authors.affiliation: Wills Eye Institute, Philadelphia, Pennsylvania3Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Julia A
authors.initials: JA
authors.lastname: Haller
authors.affiliation: Department of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Gainesville.
authors.forename: Steven T
authors.initials: ST
authors.lastname: DeKosky
mesh_terms: D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism; D000613:Aminobutyrates / Q000494:pharmacology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D057911:Angiotensin Receptor Antagonists / Q000494:pharmacology*; D000818:Animals; D001713:Biphenyl Compounds; D001921:Brain / Q000378:metabolism; D004195:Disease Models, Animal; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D000882:Haplorhini; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D051379:Mice; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000502:physiology*; D012162:Retinal Degeneration / Q000188:drug therapy / Q000209:etiology; D013777:Tetrazoles / Q000494:pharmacology*; D000068756:Valsartan
chemical_list: D000613:Aminobutyrates; D016229:Amyloid beta-Peptides; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; D015260:Neprilysin; C549068:sacubitril and valsartan sodium hydrate drug combination